Level Eight Ventures

Level Eight Ventures is a venture capital firm founded in 2018 and based in Ann Arbor, Michigan. It invests in companies across North America and Europe, focusing on artificial intelligence, clean energy, mobility, healthcare, materials and chemicals, sensors, inspection, resources and environment sectors, as well as enabling technologies in biochemistry, materials science, robotics and AI. The firm provides capital and strategic support to high-potential teams developing disruptive technologies to scale and deliver cleaner, smarter, and more sustainable solutions.

Séamus Hatch

Partner

Daniel Krausz JD

Partner

Richard Philpott Ph.D

Partner

3 past transactions

SpinTech MRI

Series A in 2022
SpinTech MRI is a developer of an advanced MRI imaging software platform designed to significantly reduce the time required for brain imaging while enhancing the visualization and automatic detection of critical biomarkers for neurological conditions. These conditions include traumatic brain injury, dementia, Parkinson's disease, multiple sclerosis, and stroke, which often go undetected with existing methods. By transforming advanced research techniques into practical clinical applications, SpinTech MRI's platform integrates seamlessly with virtually any MRI machine to provide standardized, high-quality images and quantitative biomarkers. This innovative approach aids clinicians in detecting microbleeds and quantifying neuromelanin content, ultimately improving patient outcomes and maximizing the return on investment for expensive imaging equipment. The team comprises physicists, engineers, and entrepreneurs dedicated to advancing imaging technology for patients suffering from neurological diseases.

Pathware

Series A in 2022
Pathware is a technology company developing a digital pathology platform for point-of-care diagnostics. The platform combines computational microscopy and artificial intelligence to analyze tissue samples, enabling clinicians and pathologists to diagnose and treat diseases earlier and more precisely, with the goal of improving patient outcomes and reducing diagnostic times. Its product set includes Bioptic, an automated point-of-care biopsy assessment system, along with a sample testing platform and a sample management platform designed to streamline pathology workflows. Founded in 2017 and based in Ann Arbor, Michigan, with an additional location in Seattle, Pathware focuses on bringing computational pathology tools to the bedside to support faster, more accurate decision making in healthcare.

Invision AI

Seed Round in 2017
Invision AI is focused on transforming the Internet of Things into the Internet of Intelligent Things by developing advanced AI software that operates directly on edge devices. This approach allows for the creation of valuable situational insights without the need for expensive hardware or reliance on cloud uploads. The company has created a cloud-based video analytics platform that enhances the functionality of video monitoring technologies. By employing proprietary machine learning algorithms, Invision AI’s platform learns from existing visual data and leverages extensive datasets, which enables professionals to reduce bandwidth costs associated with traditional motion detection systems while significantly improving the user experience.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.